National Cancer Center Singapore: the way forward

Author:

Teo Melissa1,Soo Khee Chee2

Affiliation:

1. Division of Surgical Oncology, National Cancer Center Singapore, 11 Hospital Drive, Singapore 169610

2. Director, National Cancer Center Singapore, 11 Hospital Drive, Singapore 169610

Abstract

Cancer is the leading cause of death in Singapore, comprising almost 30% of annual deaths. The incidence and prevalence continue to rise, resulting in Singapore having the highest age-standardized rate of cancer in southeast Asia. A review of national health policies in 1992 resulted in the creation of a National Cancer Centre Singapore (NCCS) in 1999. The current NCCS, with its three pillars of clinical service, research and education, manages about 70% of all new cancer cases in the countries public healthcare system. As it outgrows its current outfit and looks to the new NCCS building in 2020, the goal must be for strategic planning to attract and retain the best minds and heart in the field of cancer if it were to continue to be successful in achieving its vision and mission. This article chronicles the NCCS's history and details the foundation of its strategic plans.

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

Reference7 articles.

1. International Agency for Research on Cancer. www.iarc.fr.

2. Singapore Cancer Registry Annual Registry Report. Trends in Cancer Incidence in Singapore 2009–2013. National Registry of Diseases Office (2014). www.nrdo.gov.sg/docs/librariesprovider3/Publications-Cancer/cancer-trends-report-2009-2013.pdf?sfvrsn=0&AspxAutoDetectCookieSupport=1.

3. Affordable health care: a White Paper. Singapore's Review Committee of National Health Policies. http://eresources.nlb.gov.sg/printheritage/detail/4c3b0b9a-60e4-4a08-a575-2b731e4973bc.aspx.

4. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Asian Patients: 100 Consecutive Patients in a Single Institution

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3